Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases

OBJECTIVES: Extensive application of anti-HER2 targeted therapy improves significantly the HER2-positive advanced breast cancer (BC) prognosis, however, it is still difficult to treat brain metastasis. In current study, we explored effective approaches via combining pyrotinib to treat brain metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaoping, Li, Yan, Li, Li, Gao, Chunyan, Liu, Dan, Li, Hongyu, Zhao, Zhenhui, Zhao, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639475/
https://www.ncbi.nlm.nih.gov/pubmed/36331291
http://dx.doi.org/10.1080/07853890.2022.2139411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639475/
https://www.ncbi.nlm.nih.gov/pubmed/36331291
http://dx.doi.org/10.1080/07853890.2022.2139411

Ejemplares similares